Steven M. Altschuler, M.D.
Dr. Altschuler was most recently EVP for Health Affairs at the University of Miami, and CEO of UHealth, Miami Univertity’s health system. He was CEO of Children’s Hospital of Philadelphia from 2000 to 2015, during which time he led its transition from a traditional academic medical center and specialty hospital to a global leader in pediatric healthcare, research, education, and advoacy for children. He currently serves on the boards of AsclepiX Therapeutics, 89bio, ImVax, Orchard Therapeutics and WW (formerly Weight Watchers International).
- March 2021
Added to: PlateletBio - Watertown, MA
PlateletBio is a pioneering biotechnology company developing next-generation allogeneic cell therapies for the treatment of human diseases. Their cell therapy platform produces "platelet-like cells" capable of performing vital biological functions and are able to be genetically engineered into multiple allogeneic therapies.